ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
1.820
+0.035 (1.96%)
Jul 22, 2024, 10:14 AM EDT - Market open
ProQR Therapeutics Employees
ProQR Therapeutics had 157 employees as of December 31, 2023. The number of employees increased by 26 or 20.28% compared to the previous year.
Employees
157
Change (1Y)
26
Growth (1Y)
20.28%
Revenue / Employee
$93,620
Profits / Employee
-$186,324
Market Cap
148.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Lifecore Biomedical | 459 |
Quantum-Si incorporated | 159 |
Zomedica | 144 |
Alpha Tau Medical | 121 |
Myomo | 106 |
Capricor Therapeutics | 102 |
Elevation Oncology | 29 |
PRQR News
- 2 months ago - ProQR Announces First Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024 - GlobeNewsWire
- 3 months ago - ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting - GlobeNewsWire
- 3 months ago - ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio - GlobeNewsWire
- 4 months ago - ProQR Announces Year End 2023 Operating and Financial Results - GlobeNewsWire
- 6 months ago - ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024 - GlobeNewsWire
- 7 months ago - ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration - GlobeNewsWire
- 8 months ago - ProQR Therapeutics Announces Transaction Completed for Théa to Acquire Sepofarsen and Ultevursen Ophthalmic Assets - GlobeNewsWire